The product patent from Eurasia (020227), one product patent from Japan (5540099) and one product patent from Mexico (319429) corresponding to the New Chemical Entities for the treatment of disorders associated with neurodegenerative diseases and these patents are valid through 2029, the company said in a release today.
With these new patents, Suven has a total of thirteen granted patents from Eurasia, 12 granted patents from Japan and 17 product patents from Mexico. Products out of these inventions may be out-licensed at various phases of clinical development like at Phase-1 or Phase-II, the release said.
The stock opened at Rs 208 and touched a high of Rs 220. At 10:15AM, over 340,000 shares were traded on the BSE and NSE.